Hematologic Malignancy
Follicular Helper T-Cell Lymphoma
CI-CAN-00007714Explore in graph →
Hematologic17 active trials
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00007714Explore in graph →
Clinical trials
126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (24)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03593018 | Efficacy and Safety of Oral Azacitidine Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory AITL | completed | Phase 3 | 86 | The Lymphoma Academic Research OrganisationOTHER | 5 | Apr 23, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Apr 23, 2026source: clinicaltrials